Assessing residual visual function in severe vision loss

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 3, 2014, Pages 1332-1338

  Ayton, Lauren N ^a   Apollo, Nicholas V ^a   Varsamidis, Mary ^a   Dimitrov, Peter N ^a   Guymer, Robyn H ^a   Luu, Chi D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Electroretinography; Low vision; Retinitis pigmentosa; Vision regeneration; Visual function

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAM; FOURIER TRANSFORMATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETINA; RETINITIS PIGMENTOSA; SIGNAL NOISE RATIO; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VERY ELDERLY; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ELECTRORETINOGRAPHY; LOW VISION; RETINITIS PIGMENTOSA; VISION REGENERATION; VISUAL FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETINA; RETINITIS PIGMENTOSA; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE; VISION, LOW; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84895879787     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12657     Document Type: Article

References (38)

1. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.
2. Jacobson SG, Cideciyan AV, Ratnakaram R, et al. Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol. 2012;130:9-24.
3. Schwartz SD, Hubschman JP, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379:713-720.
4. Humayun MS, Dorn JD, da Cruz L, et al. Interim results from the international trial of Second Sight's visual prosthesis. Ophthalmology. 2012;119:779-788.
5. Zrenner E, Bartz-Schmidt KU, Benav H, et al. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci. 2011;278:1489-1497.
6. Bittner AK, Ibrahim MA, Haythornthwaite JA, et al. Vision test variability in retinitis pigmentosa and psychosocial factors. Optom Vis Sci. 2011;88:1496-1506.
7. Chung ST, Bailey IL, Dagnelie G, et al. New challenges in lowvision research. Optom Vis Sci. 2012;89:1244-1245.
8. Ross DF, Fishman GA, Gilbert LD, Anderson RJ. Variability of visual field measurements in normal subjects and patients with retinitis pigmentosa. Arch Ophthalmol. 1984;102:1004-1010.
9. Bjork A, Karpe G. The electroretinogram in retinitis pigmentosa. Acta Ophthalmol. 1951;29:361-376.
10. Sieving PA, Arnold EB, Jamison J, et al. Submicrovolt flicker electroretinogram: cycle-by-cycle recording of multiple harmonics with statistical estimation of measurement uncertainty. Invest Ophthalmol Vis Sci. 1998;39:1462-1469.
11. Bach M, Meigen T. Do's and don'ts in Fourier analysis of steadystate potentials. Doc Ophthalmol. 1999;99:69-82.
12. Hassan-Karimi H, Jafarzadehpur E, Blouri B, et al. Frequency domain electroretinography in retinitis pigmentosa versus normal eyes. J Ophthalmic Vis Res. 2012;7:34-38.
13. Andreasson SO, Sandberg MA, Berson EL. Narrow-band filtering for monitoring low-amplitude cone electroretinograms in retinitis pigmentosa. Am J Ophthalmol. 1988;105: 500-503.
14. Henke HE, van der Tweel LH, van der Gon JJD. Selective amplification of the electroretinogram. Ophthalmologica. 1956;132:140-150.
15. Armington JC, Gouras P, Tepas DI, Gunkel RD. Detection of the electroretinogram in retinitis pigmentosa. Exp Eye Res. 1961;1:74-80.
16. Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:761-772.
17. Birch DG, Sandberg MA. Submicrovolt full-field cone electroretinograms: artifacts and reproducibility. Doc Ophthalmol. 1996;92:269-280.
18. Dagnelie G, Massof RW. Sub-microvolt electroretinograms: negotiating the pitfalls of photoelectricity and noise. Vision Science and Its Applications (Technical Digest Series). Vol. 2. Washington, DC: Optical Society of America; 1994:269-280.
19. Colenbrander A. Visual standards-aspects and ranges of vision loss with emphasis on population surveys. In: Report for the International Council of Ophthalmology. Sydney, Australia, International Council of Ophthalmology; 2002:1-33.
20. ETDRS. Early Treatment Diabetic Retinopathy Study. Baltimore, MD: ETDRS Coordinating Center, Department of Epidemiology and Preventive Medicine; 1980.
21. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976;53:740-745.
22. Bailey IL, Jackson AJ, Minto H, et al. The Berkeley Rudimentary Vision Test. Optom Vis Sci. 2012;89:1257-1264.
23. Bittner AK, Iftikhar MH, Dagnelie G. Test-retest: within-visit variability of Goldmann visual fields in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2011;52:8042-8046.
24. Marmor MF, Fulton AB, Holder GE, et al. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69-77.
25. Dawson WW, Trick GL, Litzkow CA. Improved electrode for electroretinography. Invest Ophthalmol Vis Sci. 1979;18:988-991.
26. Ayton LN, Rizzo JF. Psychophysical testing of visual prosthetic devices: a call to establish a multi-national joint task force. J Neural Eng. In press.
27. Spector RH. Visual fields. In: Walker HK, Hall WD, Hurst JW, eds. Clinical Methods: The History, Physical and Laboratory Examinations. 3rd ed. Boston: Butterworths; 1990. http:// www.ncbi.nlm.nih.gov/books/NBK220/. Accessed March 1, 2013.
28. Chan HL, Brown B. Investigation of retinitis pigmentosa using the multifocal electroretinogram. Ophthalmic Physiol Opt. 1998;18:335-350.
29. Janaky M, Palffy A, Deak A, et al. Multifocal ERG reveals several patterns of cone degeneration in retinitis pigmentosa with concentric narrowing of the visual field. Invest Ophthalmol Vis Sci. 2007;48:383-389.
30. Moon CH, Park TK, Ohn YH. Association between multifocal electroretinograms, optical coherence tomography and central visual sensitivity in advanced retinitis pigmentosa. Doc Ophthalmol. 2012;125:113-122.
31. Nagy D, Schonfisch B, Zrenner E, Jagle H. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography. Invest Ophthalmol Vis Sci. 2008;49:4664-4671.
32. Seeliger M, Kretschmann U, Apfelstedt-Sylla E, et al. Multifocal electroretinography in retinitis pigmentosa. Am J Ophthalmol. 1998;125:214-226.
33. Sliesoraityte I, Troeger E, Bernd A, et al. Correlation between spectral domain OCT retinal nerve fibre layer thickness and multifocal pattern electroretinogram in advanced retinitis pigmentosa. Adv Exp Med Biol. 2012;723:471-478.
34. Wen Y, Klein M, Hood DC, Birch DG. Relationships among multifocal electroretinogram amplitude, visual field sensitivity, and SD-OCT receptor layer thicknesses in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2012;53: 833-840.
35. Granse L, Ponjavic V, Andreasson S. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields. Acta Ophthalmol Scand. 2004;82:701-706.
36. Holopigian K, Shuwairi SM, Greenstein VC, et al. Multifocal visual evoked potentials to cone specific stimuli in patients with retinitis pigmentosa. Vision Res. 2005;45:3244-3252.
37. Paranhos FR, Katsum O, Arai M, et al. Pattern reversal visual evoked response in retinitis pigmentosa. Doc Ophthalmol. 1998;96:321-331.
38. De Rouck A, Leys M. Pattern reversal VEP in retinitis pigmentosa. Bull Soc Belge Ophtalmol. 1987;223(pt 2):83-89.